Future Vitilgo treatments
-
- Posts: 832
- Joined: Wed Sep 07, 2016 4:12 pm
Future Vitilgo treatments
Hello
I was hoping someone could advise on any new treatments or the possibility of possible cures for vitiligo in the near future? Thank you Kerry
I was hoping someone could advise on any new treatments or the possibility of possible cures for vitiligo in the near future? Thank you Kerry
talkhealth team on behalf of a guest visitor
- Julie Van Onselen
- Posts: 57
- Joined: Wed Aug 31, 2016 10:02 am
Re: Future Vitilgo treatments
Dear Kerry
Thank you for your post and question. There are so very exciting development in dermatology treatments, which are targeting biologic treatments and oak-inhibitors.
A new cream called Opzelura®, which contains the active substance ruxolitinib, is the first approved topical JAK 1/2 inhibitor for vitiligo and has been approved for use in Europe and the UK, but only currently for private prescription. NICE are currently conducting a technology appraisal, and hopefully it will be approved for NHS prescription in the future.
Opzelura works by:
Halting depigmentation – by selectively binding to JAK1 and JAK2
Inducing repigmentation – melanocytes migrate from hair follicles and lesion edges
Preventing relapses – selective JAK1 binding inhibiting signal transmission by IL-15
I hope this information is useful.
Thank you for your post and question. There are so very exciting development in dermatology treatments, which are targeting biologic treatments and oak-inhibitors.
A new cream called Opzelura®, which contains the active substance ruxolitinib, is the first approved topical JAK 1/2 inhibitor for vitiligo and has been approved for use in Europe and the UK, but only currently for private prescription. NICE are currently conducting a technology appraisal, and hopefully it will be approved for NHS prescription in the future.
Opzelura works by:
Halting depigmentation – by selectively binding to JAK1 and JAK2
Inducing repigmentation – melanocytes migrate from hair follicles and lesion edges
Preventing relapses – selective JAK1 binding inhibiting signal transmission by IL-15
I hope this information is useful.
Julie Van Onselen
Independent Dermatology Nurse
http://www.talkhealthpartnership.com/on ... nselen.php
Independent Dermatology Nurse
http://www.talkhealthpartnership.com/on ... nselen.php